# Novartis Pharmaceuticals Corporation – FDA Inspection, Feb 6, 2026

Source: https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/dda9986d-7403-4915-9abe-66007c22736d
Source feed: FDA_Inspections

> FDA inspection 1300144 of Novartis Pharmaceuticals Corporation, February 06, 2026. 3 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1300144
- Company Name: Novartis Pharmaceuticals Corporation
- Inspection Date: 2026-02-06
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: New Jersey District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 1245942 - 2024-08-08](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/d2f19248-2be2-424d-85b3-a50251928268)
- FDA Inspection 1194474 - 2022-12-09
- [FDA Inspection 1100101 - 2019-08-21](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/e4fab4a0-2d49-44f2-a6c8-f6170fd44cd2)
- [FDA Inspection 1019194 - 2017-04-07](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/9ab30769-64e6-41c7-bcc0-e04710bf5034)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/christian-d-lynch/3b2748d3-3800-4538-939d-71a33dca0b2d)
- [Issuing Officer](https://www.keypedia.com/people/christian-lynch/ee342d8e-9fcf-4c84-9494-ceaf6320faf6)
- [FDA Personnel](https://www.keypedia.com/people/lizaida-perez/686fbdca-bfd7-4a73-990a-d8a97e6b88b7)

Company: https://www.keypedia.com/companies/novartis-pharmaceuticals-corporation/21559fd5-35ed-4cbd-b228-623dd76bcf47

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248